Hong Chul Jin

Title: Innovations by Hong Chul Jin

Introduction

Hong Chul Jin is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of stabilized pemetrexed formulations. With a total of 2 patents to his name, his work has the potential to impact the medical industry positively.

Latest Patents

Hong Chul Jin's latest patents focus on a stabilized pemetrexed formulation. The first patent describes a formulation that includes acetylcysteine as an antioxidant and sodium citrate as a buffering agent. This formulation is designed to enhance the stability of pemetrexed, a drug used in cancer treatment. The second patent also relates to a stabilized pemetrexed formulation, emphasizing the use of acetylcysteine as an antioxidant and a citrate salt as a buffer. Both patents highlight the importance of maintaining low oxygen gas content within the sealed container to ensure the efficacy of the formulation.

Career Highlights

Hong Chul Jin is currently associated with CJ Healthcare Corporation, where he continues to innovate in the pharmaceutical sector. His work is crucial in developing formulations that can improve patient outcomes and enhance the stability of important medications.

Collaborations

He collaborates with talented coworkers, including Young Joon Park and Myung Jin Shin, who contribute to the innovative environment at CJ Healthcare Corporation.

Conclusion

Hong Chul Jin's contributions to the field of pharmaceutical formulations demonstrate his commitment to advancing medical science. His patents on stabilized pemetrexed formulations are a testament to his innovative spirit and dedication to improving healthcare solutions.